Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Investigator-Blinded, Randomized, Parellel Group Study to Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA 325 Versus Enteric-Coated Aspirin.

NCT00442052 is registered in ClinicalTrials.gov with POZEN as lead sponsor.

NCT NCT00442052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00442052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Investigator-Blinded, Randomized, Parellel Group Study to Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA 325 Versus Enteric-Coated Aspirin.
Lead sponsor
POZEN
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2006
Completion date
January 31, 2007
Enrollment
80
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy